Day trading pre-market open September 3, page-100

  1. 10,864 Posts.
    lightbulb Created with Sketch. 294
    Neuroscientific Biopharmaceuticals NSB
    developing novel peptide-based pharmaceutical products that target a number of neurological disorders such as Alzheimers, Dementia, Multiple Sclerosis and even eye diseases like Glaucoma.

    MCAP 19.6M
    SOI only 78M with top 20 holding 60.19%
    Cash in bank $3.28M

    https://www.barchart.com/stocks/quotes/NSB.AX/opinion

    gives NSB a 100% 'Buy rating' across all technical chart indicators

    DYOR .. Cheers tela
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.